• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

The most important objective dry eye test is TBUT with fluorescein, ODs say

Article

In a poll fielded on the Optometry Times website, we asked ODs what objective test for dry eye they think is the most important.

View the poll here

A total of 265 responses were tallied. The multiple-choice poll answers included:
• Conjunctival staining
• Corneal staining
• MMP-9
• Meibography
• Meibography gland expression
• Non-invasive tear film break-up time
• Phenol red thread test
• Schirmer
• Tear osmolarity
• Tear film break-up time with fluorescein

Related: Blog: Examine evaporative dry eye disease exposure in your patients

In first place-but not overwhelmingly so-is tear film break-up time with fluorescein as the most important objective dry eye test with 33 percent of respondents making this choice.

After a sharp drop, corneal staining was second choice. Only 17 percent of respondents think it’s the most important objective test.

Related: Explore the relationship between dry eye and sleep

Third and fourth place were close: 12 percent of ODs think tear osmolarity testing is most important, and 11 percent think non-invasive tear break-up time is.

Conjunctival staining comes in fifth with 9 percent of respondents.

Schirmer hits the sixth spot with 7 percent of ODs thinking it is most important.

Related: Ophthalmic community focusing on DED education

Meibography follows in seventh place (5 percent).

Tied for last as the most important objective dry eye test are MMP-9  and phenol red thread test with 1 percent of respondents.

Related: Understanding prevalence, demographics of dry eye disease

Related Videos
Megan Cavet, PhD
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times about the benefits of Vevye in the treatment of dry eye
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
© 2024 MJH Life Sciences

All rights reserved.